Name
MS Medisol OÜ
Registry code
11903768
VAT number
EE101395478
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
05.03.2010 (14)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
72111 - Research and experimental development on biotechnology
69 893 €
8 269 €
12%
2 984 €
(estimate is approximate)
17 684 €
1
Submitted
No tax arrears
47%
42%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Moonika Faster 07.10.1976 (48) | 100% - 2 556.00 EUR | Board member | Direct ownership | Founder |
| 2019 08.10.2020 | 2020 22.07.2021 | 2021 14.07.2022 | 2022 26.06.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 59 853 € | 70 415 € | 65 611 € | 70 732 € | 69 893 € |
| Net profit (loss) for the period | 22 718 € | 37 001 € | 31 305 € | 41 046 € | 8 269 € |
| Profit Margin | 38% | 53% | 48% | 58% | 12% |
| Current Assets | 36 865 € | 46 041 € | 41 325 € | 49 375 € | 19 857 € |
| Fixed Assets | - | - | - | - | - |
| Total Assets | 36 865 € | 46 041 € | 41 325 € | 49 375 € | 19 857 € |
| Current Liabilities | 1 272 € | 1 665 € | 644 € | 1 660 € | 2 173 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 35 593 € | 44 376 € | 40 681 € | 47 715 € | 17 684 € |
| Employees | 1 | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 13 028.87 € | 4 979.5 € | 4 968.75 € | - |
| 2023 Q4 | 19 165.27 € | 13 987.25 € | 7 237.46 € | - |
| 2023 Q3 | 16 005.4 € | 4 968.75 € | 4 968.75 € | - |
| 2023 Q2 | 19 506.59 € | 4 306.25 € | 4 306.25 € | - |
| 2023 Q1 | 15 430.36 € | 3 975.75 € | 3 975 € | - |
| 2022 Q4 | 17 976.83 € | 10 915.34 € | 5 377.47 € | - |
| 2022 Q3 | 20 004.35 € | 1 068.14 € | 1 039.86 € | - |
| 2022 Q2 | 17 608.3 € | 1 039.86 € | 1 039.86 € | - |
| 2022 Q1 | 14 903.92 € | 1 003.01 € | 1 002.76 € | - |
| 2021 Q4 | 18 862.09 € | 1 238.08 € | 1 238.08 € | - |
| 2021 Q3 | 10 317.8 € | 11 006.06 € | 4 271.49 € | - |
| 2021 Q2 | 18 342.07 € | 3 313 € | 3 312.5 € | - |
| 2021 Q1 | 19 061.64 € | 2 651.75 € | 2 650 € | 1 |
| 2020 Q4 | 16 257.94 € | 8 917.2 € | 2 950.57 € | 1 |
| 2020 Q3 | 18 731.59 € | 1 988.25 € | 1 987.5 € | 1 |
| 2020 Q2 | 15 512.39 € | 2 055 € | 1 987.5 € | 1 |
| 2020 Q1 | 19 293.04 € | 2 453.59 € | 2 237.5 € | 1 |
